KALBERMATTEN ADAM R
Chief Commercial Officer
KALBERMATTEN ADAM R has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Sep 9, 2026.
On the most recent filing, KALBERMATTEN ADAM R is listed as Chief Commercial Officer at KORU Medical Systems, Inc. Inside the rolling window, KALBERMATTEN ADAM R reported 2 open-market purchases totaling $150K in KRMD and no open-market sales. The largest disclosed transaction in the window is a purchase of 32,000 KRMD shares on Sep 8, 2026, worth $101K.
Companies traded
Other insiders at KRMD
Insider Buying
$150K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has KALBERMATTEN ADAM R made?
KALBERMATTEN ADAM R has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does KALBERMATTEN ADAM R trade?
KALBERMATTEN ADAM R has filed SEC Form 4 disclosures for 1 company, including KRMD.
When was KALBERMATTEN ADAM R's most recent SEC Form 4 filing?
KALBERMATTEN ADAM R's most recent SEC Form 4 filing on Tracefour is dated Sep 9, 2026.
What is KALBERMATTEN ADAM R's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, KALBERMATTEN ADAM R is listed as Chief Commercial Officer.
What is KALBERMATTEN ADAM R's total buy and sell value in the current window?
Inside the rolling retention window, KALBERMATTEN ADAM R bought $150K and sold $0 based on SEC Form 4 filings.
What was KALBERMATTEN ADAM R's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 32,000 KRMD shares on 2026-09-08, worth $101K, per SEC Form 4 filings.